We serve Chemical Name:4-[2-(3-Bromophenoxy)ethyl]morpholine CAS:435283-95-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![4-[2-(3-Bromophenoxy)ethyl]morpholine](https://a.dearchem.com/CAS2/435283-95-7.png)
Chemical Name:4-[2-(3-Bromophenoxy)ethyl]morpholine
CAS.NO:435283-95-7
Synonyms:4-[2-(3-Bromophenoxy)ethyl]morpholine;4-(2-(3-Bromophenoxy)ethyl)morpholine;Morpholine, 4-[2-(3-bromophenoxy)ethyl]-
Molecular Formula:C12H16BrNO2
Molecular Weight:286.165
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:367.2±32.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.548
PSA:21.70000
Exact Mass:285.036438
LogP:2.38
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-[2-(3-Bromophenoxy)ethyl]morpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Morpholine, 4-[2-(3-bromophenoxy)ethyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[2-(3-Bromophenoxy)ethyl]morpholine Use and application,4-[2-(3-Bromophenoxy)ethyl]morpholine technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. 4-[2-(3-Bromophenoxy)ethyl]morpholine manufacturer Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 4-[2-(3-Bromophenoxy)ethyl]morpholine supplier If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. 4-[2-(3-Bromophenoxy)ethyl]morpholine vendor However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. 4-[2-(3-Bromophenoxy)ethyl]morpholine factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.
